Lansforsakringar Fondforvaltning AB (publ)
Position in NBIX — Neurocrine Biosciences Inc
CIK 2059323
Stockholm, V7
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,515,523
+$314,598 QoQ
Shares Held
26,792
-16.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#228
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $29,337,552 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (15.4% of the industry book) .
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,515,523 | 26,792 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,200,925 | 31,888 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,522,675 | 31,888 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,420,706 | 31,491 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,958,103 | 31,491 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,588,527 | 32,446 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,428,879 | 32,446 | Shares | Sole | 2025-03-14 | |
| No filing history on record for this holder in this stock. | ||||||